# Peripheral Blood Flow Responses to Electromagnetic Energy

> **NCT02370199** · NA · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 40 (estimated)

## Conditions studied

- Exposure to Man-made Visible Light

## Interventions

- **DEVICE:** 670 nm light
- **DRUG:** octafluropropane

## Key facts

- **NCT ID:** NCT02370199
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-11
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02370199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02370199, "Peripheral Blood Flow Responses to Electromagnetic Energy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02370199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*